Virus
US12016949B2 · kind B2 · utility
0Cited by
6References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 5, 2018 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Jun 9, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is in the field of delivery of transgenes to target cells using viral vectors, particularly in the field of gene therapy. Compositions have been identified which allow for oral administration of viral particles, particularly adenoviral particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.